Literature DB >> 6286388

Stimulation and inhibition by LHRH analogues of cultured rat Leydig cell function and lack of effect on mouse Leydig cells.

M G Hunter, M H Sullivan, C J Dix, L F Aldred, B A Cooke.   

Abstract

The effect of 2 luteinizing hormone-releasing hormone (LHRH) analogues(10-8-10-6 M) on the functional activity (testosterone and cyclic AMP production and [125I]hCG binding) of purified mouse Leydig cells in culture was examined. The analogues were found to have no significant effect on the cells over a period of 3 days. No specific binding of a labelled analogue to impure or pure mouse Leydig cells could be detected. In contrast high levels of specific binding to impure rat interstitial cells occurred. Centrifugation of the rat interstitial cells on 0-90% Percoll gradients showed that the LHRH analogue bound specifically to the active lutropin-responsive Leydig cells. The purified rat Leydig cells were cultured in the presence of LHRH analogue (ICI 118630) (10-7 M) and after an initial lag period (2h) a marked stimulation of testosterone production occurred over a 32-h period (up to 400 ng/10(6) cells). The response to LH alone increased with time in culture up to 10 h, and the LHRH analogue enhanced this LH-stimulated testosterone production. When the cells were cultured for longer time periods (24 h) the LHRH analogue was found to inhibit LH-stimulated testosterone production at all concentrations of LH used (p less than 0.01). The LHRH analogue had no consistent effect on LH-stimulated cyclic AMP production, although when added alone, cyclic AMP production was increased. These results show that LHRH analogues do not bind to or have any detectable effect on mouse Leydig cells in vitro. However, LHRH analogue does bind specifically to purified rat Leydig cells. After a short lag period the analogue stimulates testosterone production which turns to inhibition after 20 h in culture.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286388     DOI: 10.1016/0303-7207(82)90060-0

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  13 in total

1.  Control and production of leukotriene B4 in rat tumour and testicular Leydig cells.

Authors:  M H Sullivan; B A Cooke
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

2.  Evidence for the rapid internalization and recycling of lutropin receptors in rat testis Leydig cells.

Authors:  A D Habberfield; C J Dix; B A Cooke
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

Review 3.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

4.  Inhibition of steroid production in Leydig cells by non-steroidal anti-inflammatory and related compounds: evidence for the involvement of lipoxygenase products in steroidogenesis.

Authors:  C J Dix; A D Habberfield; M H Sullivan; B A Cooke
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

5.  Steroidogenic effect of atrial natriuretic factor in isolated mouse Leydig cells is mediated by cyclic GMP.

Authors:  A K Mukhopadhyay; M Schumacher; F A Leidenberger
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

6.  Ultrastructural analysis of the effect of ethane dimethanesulphonate on the testis of the rat, guinea pig, hamster and mouse.

Authors:  J B Kerr; C M Knell; M Abbott; K Donachie
Journal:  Cell Tissue Res       Date:  1987-08       Impact factor: 5.249

7.  The role of calcium in luteinizing hormone-releasing hormone agonist (ICI 118630)-stimulated steroidogenesis in rat Leydig cells.

Authors:  M H Sullivan; B A Cooke
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

8.  Unresponsiveness of the reproductive organs of the male mouse to treatment with a potent luteinizing hormone-releasing hormone agonist (ICI-118,630).

Authors:  G J van Steenbrugge; J C Romijn; F H de Jong; F H Schröder
Journal:  Urol Res       Date:  1984

9.  Does a gonadotropin-releasing hormone analogue prevent cisplatin-induced spermatogenic impairment? An experimental study in the mouse.

Authors:  M Nonomura; K Okada; S Hida; O Yoshida
Journal:  Urol Res       Date:  1991

10.  Stimulation of cholesterol side-chain cleavage by a luteinizing-hormone-releasing hormone (luliberin) agonist (ICI 118630) in rat Leydig cells.

Authors:  M H Sullivan; B A Cooke
Journal:  Biochem J       Date:  1983-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.